Miss Hang Su
Research outputs (1)
Economic evaluation of Tislelizumab Versus Chemotherapy as Second Line Treatment for Advanced or Metastatic Esophageal Squamous Cell Carcinoma in China
Research output: Contribution to journal › Article › peer-review